Convergence Investment Partners, LLC Bristol Myers Squibb CO Transaction History

Convergence Investment Partners, LLC

$261 Million
Q1 2024

A detailed history of Convergence Investment Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 16,614 shares of BMY stock, worth $658,911. This represents 0.35% of its overall portfolio holdings.

Number of Shares

16,614

Previous 10,198 62.91%

Holding current value

$658,911

Previous $523,000 72.28%

% of portfolio

0.35%

Previous 0.27%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$47.98 - $54.4 $307,839 - $349,030	6,416 Added 62.91%	16,614 $901,000
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $51,873 - $61,899	1,070 Added 11.72%	10,198 $523,000
Q3 2023 Nov 02, 2023	BUY	$57.89 - $64.73 $59,626 - $66,671	1,030 Added 12.72%	9,128 $530,000
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $39,755 - $44,141	-624 Reduced 7.15%	8,098 $518,000
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $6,768 - $7,676	-103 Reduced 1.17%	8,722 $604,000

Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $74,985 - $88,793	-1,095 Reduced 11.04%	8,825 $634,000
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $42 - $24,973	-325 Reduced 3.17%	9,920 $705,000
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $121,348 - $133,646	1,671 Added 19.49%	10,245 $789,000
Q1 2022 Apr 26, 2022	BUY	$61.48 - $73.72 $177,431 - $212,755	2,886 Added 50.74%	8,574 $626,000
Q4 2021 Jan 25, 2022	SELL	$53.63 - $62.52 $15,016 - $17,505	-280 Reduced 4.69%	5,688 $355,000
Q3 2021 Oct 25, 2021	BUY	$59.17 - $69.31 $56,389 - $66,052	953 Added 19.0%	5,968 $353,000
Q2 2021 Jul 19, 2021	SELL	$61.91 - $67.42 $18,077 - $19,686	-292 Reduced 5.5%	5,015 $335,000
Q1 2021 Apr 30, 2021	SELL	$59.34 - $66.74 $1,186 - $1,334	-20 Reduced 0.38%	5,307 $335,000
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $519 - $588	-9 Reduced 0.17%	5,327 $330,000
Q3 2020 Oct 28, 2020	SELL	$57.43 - $63.64 $943,632 - $1.05 Million	-16,431 Reduced 75.49%	5,336 $322,000
Q2 2020 Jul 30, 2020	BUY	$54.82 - $64.09 $108,982 - $127,410	1,988 Added 10.05%	21,767 $1.28 Million
Q1 2020 Apr 23, 2020	SELL	$46.4 - $67.43 $475,924 - $691,629	-10,257 Reduced 34.15%	19,779 $1.1 Million
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $448,844 - $585,476	9,121 Added 43.61%	30,036 $1.93 Million
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $894,534 - $1.06 Million	20,915 New	20,915 $1.06 Million
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $796,503 - $949,731	-17,653 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $860,760 - $1.12 Million	17,653 New	17,653 $918,000
Q2 2018 Aug 07, 2018	SELL	$50.53 - $62.98 $144,667 - $180,311	-2,863 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $4.57 Million - $5.26 Million	-76,260 Reduced 96.38%	2,863 $181,000
Q4 2017 Jan 16, 2018	BUY	$59.94 - $65.35 $200,799 - $218,922	3,350 Added 4.42%	79,123 $4.85 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $4.18 Million - $4.83 Million	75,773	75,773 $4.83 Million

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.

Account

Convergence Investment Partners, LLC Bristol Myers Squibb CO Transaction History